Search results
Results from the WOW.Com Content Network
In 1911, the anaesthetist Arthur Ernest Guedel first described the use of self-administration of a nitrous oxide and oxygen mix. It was not until 1961 that the first paper was published by Michael Tunstall and others, describing the administration of a pre-mixed 50:50 nitrous oxide and oxygen mix, which led to the commercialisation of the product.
Nitrous oxide (N 2 O), commonly referred to as laughing gas, along with various street names, is an inert gas which can induce euphoria, dissociation, hallucinogenic states of mind, and relaxation when inhaled. [1] Nitrous oxide has no acute biochemical or cellular toxicity and is not metabolized in humans or other mammals.
The effect is named after Bernard Raymond Fink (1914–2000), whose 1955 paper first explained it. [ 1 ] [ 4 ] When a patient is recovering from N 2 O anaesthesia , large quantities of this gas cross from the blood into the alveoli (down its concentration gradient ) and so for a short period of time, the O 2 and CO 2 in the alveoli are diluted ...
In the developed world, the most frequent type in use is the continuous-flow anaesthetic machine or "Boyle's machine", which is designed to provide an accurate supply of medical gases mixed with an accurate concentration of anaesthetic vapour, and to deliver this continuously to the patient at a safe pressure and flow.
Nitrous oxide flow is only allowed via an opened valve when there is flow of oxygen to the system. In any circumstances when oxygen flow is less than 30%, nitrous oxide stops flowing. This prevents the potential delivery of 100% nitrous oxide and it becomes a standard on every sedation unit made today. [9] Reservoir bag
Subsequently, about 40 years later, in 1581, Giambattista Delia Porta demonstrated the use of ether on humans although it was not employed for any type of surgical anesthesia. [14] In modern medicine, Dr. Horace Wells used nitrous oxide for his own dental extraction in 1844.
Monitoring of methemoglobin needed when nitric oxide is in use. Nitric oxide with oxygen (O 2) in combination produces another by-product chemical compound nitrogen dioxide (NO 2). The higher the oxygen concentration and nitric oxide therapy duration and lower ventilator flow rate the higher amount of NO 2 will be produced. NO 2 is toxic and its
These effects occur because of the contraction of alveolar volume associated with the uptake of the nitrous oxide. Previous explanations by Edmond I. Eger and Robert K. Stoelting have appealed to an extra-inspired tidal volume due to a potential negative intrapulmonary pressure associated with the uptake of the nitrous oxide. [2]